VC, Life Sciences, Biotech

Radius Adds $15M to Series C

Ryan McBride 11/20/08

Radius Health, a Cambridge, MA-based developer of drugs for osteoporosis and women’s health, says it has added $15 million more to its Series C round of venture capital, which now totals $82.5 million, with investments from MPM Capital, the Wellcome Trust, HealthCare Ventures, Oxford Bioscience Partners, BB Biotech Ventures, and Scottish Widows Investment Partnership. The company has raised a total of $106.5 million in venture capital.